GENEVA, Nov. 4 -- SHIFTBIO INC. (102-ho, 76 Hwarang-ro,Seongbuk-gu,Seoul 02751), 주식회사 시프트바이오 (서울특별시성북구화랑로 76, 102호) filed a patent application (PCT/KR2025/095276) for "METHOD FOR MASS-PRODUCING, WITH HIGH-PURITY AND HIGH-EFFICIENCY, EXTRACELLULAR VESICLES THROUGH NOVEL CELL BANK CONSTRUCTION STRATEGY, AND EXTRACELLULAR VESICLES PRODUCED THEREFROM" on Apr 22, 2025. With publication no. WO/2025/226116, the details related to the patent application was published on Oct 30, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is...